Delta4 Program

ME / CFS

Aim

Identify diagnostics and novel compounds for treatment of patients with ME/CFS.

Brief description

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a complex multisystemic disorder that affects, among other things, the immune, nervous and endocrine systems, as well as energy metabolism. A characteristic feature of the condition is so-called Post-Exertional Malaise (PEM): a marked, often delayed worsening of symptoms or the onset of new symptoms following physical or mental exertion. Diagnosis is currently based exclusively on clinical criteria.

Funding agency: European Union (Horizon Europe)
Status: Ongoing
Timeline: 2026 – 2030

Outcome / Opportunities

DISCOVER-ME Consortium Partners

Get Involved

Learn how you can contribute to the exciting work happening at Delta4

Careers

Forging the innovative treatments of the future requires brilliant minds and we’re always on the lookout for talent.

Investors

Contact us to find out more about how you can invest with us and be a part of pioneering the next successful treatment.

Medical Community

Learn how you can partner with us and combine our technology with your knowledge to develop treatments faster.